|
Back
To Articles
|
|
PSK - Coriolus Versicolor and Cancer
Townsend Letter for Doctors & Patients August/September 1997
Who Owns Your Health?
by Steven Bailey, ND
This article is sponsored by JHS Products, a proprietary company
In an ideal world, the answer to “Who owns your health?” would be a
simple “I do.” Yet, this is not an ideal world, particularly in the
arenas of personal health and health care. So many factors remove us
from ownership that even when we choose a responsible lifestyle and
diet, continue our health education and invest in a quality healthcare
policy, we are at best limited partners in this very important interest.
Many of the disempowering factors are well known to the readers of the Townsend Letter,
which strives to help reveal the misinformation perpetuated by special
interests and to provide knowledge to doctors and the public regarding
safe options in our own health decisions. In the Townsend Letter,
June 1997, both the editorial by Alan Gaby, MD “Drug Money Influences
Medical Opinions” and the letter by Lee Hitchcox, DC on healthcare
reform speak well about the problems inherent in our current healthcare
system. While I agree with many of the points and reform suggestions in
Dr. Hitchcox’s letter, their complete and immediate enaction would
still not give us ownership of our health. In the very near future
economic necessity will force the debate into addressing the structural
flaws of our current system, and away from the cut - and - paste
approach of today’s reformers.
Given our political and economic
culture, the least defensible structural flaw in our healthcare system
is the restriction on the flow of information regarding alternative
therapies. It is also the one structural flaw whose correction could go
the furthest in promoting the sort of systemic solutions that decrease
the need for a piecemeal approach to reform.
It is hard to stand against the responsible use for good science. In
theory, our free market is driven by informed and educated choice,
i.e., good science. Enlightened demand can then promote the rise of
effective health-care options as dollars flow toward the treatments
that work, and away from those that do not. The American people have
already spoken, with $14 billion being spent yearly on “alternative”
health care. Yet the government still restricts the critical component
needed for this market to function effectively, and that is good
commercial information about alternatives that work.
As Dr. Gaby pointed out in his editorial in the Townsend Letter,
June 1997, current statues and regulations severely restrict the free
flow of information regarding inexpensive, effective, and
scientifically proven treatments simply because they fall outside the
pharmaceutical/allopathic paradigm. Contrast this with the marketing
muscle of the pharmaceutical companies that dominate mass media outlets
with the profits from proprietary drug sales.
Ideally, part of
the the solution would be to redress patent laws that allow proprietary
ownership of drugs, leading to over-pricing and unfair competition
against safe, low cost, and often more effective natural, non-drug
options. Changes in these laws would not end research and development,
nor would they need to remove responsible profit margins for industry.
They would, however, help to level the playing field and limit the
early release and use of drugs that later prove harmful and must be
removed form the market.
Realistically, securing the right to inform the public, through
commercial speech, about good science on non-toxic therapies is an
obtainable goal. Within the context of public debate, there is no
credible reason - technical, legal, or economic - to stand against such
a policy. Federal bureaucrats and legislators have tackled and solved
more complicated regulatory tasks. And given that tens of thousands of
people die every year as a result of taking FDA - approved drugs and
therapies, the safety issues and risk factors involved with non-toxic
therapies, by definition, would have to fall within our collective and
regulatory comfort zone.
We need a way for science and information, rather than special-interest
economics, to drive the American health care system before ownership of
our own health is possible. Science and the free flow of information
will create the most effective tool for change, the enlightened
self-interest of an informed public. With fewer restrictions on the use
of good science in public forums, many critical health issues, now
ignored by the corporate media, might be examined at the national level.
In a national debate that gave priority to science, and not to special-interest economics:
---- We would discuss the causes of disease and prevention rather than how to manage the high costs of intervention and care.
---- We would challenge the food and agriculture industries,
recognizing the harm and long-term costs of their chemical-based
farming practices, the soil depletion it causes, and the resulting
inadequate nutritional values of our food.
---- We would challenge the erroneous concept of processed food
enrichment and dangers of toxic pesticides and fungicide consumption.
---- We would acknowledge the risks of trans-fatty acids in margarine and heat extracted oils.
Dr. Alan Gaby’s editorial on the marketing of drugs concludes with an
encouragement that we increase our efforts to inform the public about
“safe, effective, and inexpensive alternatives.” The natural products
industry will never match the marketing power of the pharmaceutical
industry, and it doesn’t need to. Truth will rise above the illusions
of greed. What is needed, is to bring regulations and statutes into
conformity with First Amendment Constitutional protections, and allow
commercial speech that contains the good scientific information sitting
in our public libraries. After all, who owns the science?
PSK - Coriolus versicolor:
A Case In Point
In 1994, I was introduced to PSK, and all-natural, high-quality extract product from the mushroom Coriolus versicolor.
A neighbor introduced me to a local mycologist who enthusiastically
told me about this remarkable product being used in Japan for the
treatment of cancer.
I listened with skepticism. I have been in
private practice 14 years, and have taught pharmacognosy, botanical
medicine and nutrition at the National College of Naturopathic
Medicine. I found it hard to believe that a product that was so well
researched, so broadly published, and offered so much potential benefit
could be unknown to me, my professors, and my peers.
My doubts were unfounded. Indeed PSK was well researched, with more
than 350 articles and studies published in medical journals; and yes,
it offered great potential benefit to a wide array of immune-related
concerns, especially cancer.
Skepticism is good when it leads to objective investigation. As I
reviewed the impressive amount of published material on PSK, I became
convinced of this product’s place in the medical system. Here is a
product, commercially available since the 1970’s, with such consistent
benefits that it might have significantly altered our approach to
treating cancer if not for the fact that:
1) PSK could not be owned and marketed as a “drug” under US law, and
2) as a food supplement, treatment related information is banned from commercial speech.
PSK acts as an immuno-modulator and is used primarily in conjunction
with chemotherapy, radiation, and surgical treatments for cancer.
Clinical studies have demonstrated significant results, results that
would make headlines if obtained through conventional treatments: 30%
vs. 10% disease-free survival for colon cancer patients over and
eight-year clinical trial when PSK was used alone and tested against a
placebo; 22% vs. 5% survival at five years for stage III lung cancer
patients who were given radiation plus PSK as opposed to radiation
alone 1;
81% vs. 64% survival at ten years for breast cancer patients who were
given chemotherapy plus PSK as opposed to chemotherapy alone 2;
73% vs. 60% survival at five years for gastric cancer patients who
combined daily PSK use with their chemotherapy as opposed to
chemotherapy alone. 3 This study, published in Lancet, found these results to be significant.4
However, safety and effectiveness are seemingly inconsequential when a
product cannot be marketed as a “drug.” Based upon the statistical
findings of more than 80 published human clinical studies, it is
probable that tens of thousands of people may have died early and/or
suffered unnecessarily from the side effects of chemotherapy and
radiation in our current cancer treatment protocols because this
effective medicine was not used nor available in the US.
In 1995, JHS Natural Products began marketing PSK as a food supplement
in the US. The product is available to both doctors and the general
public. Contact information for JHS is provided at the end of this
article.
PSK is a high molecular weight polysaccharide first isolated form the mushroom Coriolus versicolor in
the early 1970s. The mean molecular weight of PSK, as determined by
ultracentrifugation, is 94kD. The main component of the carbohydrate
moiety is glucose, with galactose, mannose, xylose and fucose as minor
components. The protein moiety is rich in acidic amino acids and
neutral amino acids, with basic amino acids in lower amounts. The main
component unit of the polysaccharide moiety is a B-glucan, with the
main chain consisting of B-(1-4) glucose polymer branched at positions
3 and 6 of the glucose. 5
This polysaccharide is found in a concentration of about 3% in most commercial Coriolus extracts but is isolated to a concentration of 33-66% in the product known as PSK. Also, PSK is the only commercial Coriolus
product that contains nitrogen. These critical quality control factors
are carefully monitored by JHS, and the PSK available through JHS
Natural Products is assayed by the University of Georgia, Complex
Carbohydrate Research Center, (Supported in part by the Department of
Energy-funded (DE-FG09-93ER-20097) Center for Plant and Microbial
Complex Carbohydrates.)
PSK has complied with LD-50 and other
safety evaluations in Japan and has been found to be extremely safe. In
the US, PSK is marketed as a food supplement and LD-50 tests have not
been required.
Pharmacologic properties in animals and humans have been extensively
evaluated. PSK has a human metabolic half-life of 18 hours with the
primary route of excretion being through the lungs. It requires very
little dependence upon renal or hepatic elimination,6 and in fact has
shown benefit in the treatment of hepatitis B and chronic hepatitis.
JHS is currently working with the National College of Naturopathic
Medicine to develop and fund an independent study of PSK’s influence on
chronic hepatitis C.
The studies on PSK have demonstrated benefit through a variety of
immune actions in human, animal, and in-vitro research. They have shown
PSK activating macrophage and T killer-cell activity, stimulating
lymphocyte counts, and balancing helper/suppressor ratios. Human
studies, combining PSK with a variety of different protocols, have
concluded that daily use of PSK results in significant increases in
both survival rates and periods of remission for a number of cancers.
Used extensively in Japan, where it accounts for approximately 25% of
national (insurance) expenditures for the chemical treatment of cancer,
the majority of studies investigate PSK with gastric and colorectal
cancers.
The actions of PSK appear to benefit people with many forms of cancers
as its influence is on maintaining a strong immune function during
chemical and treatment-based insult as well as stimulating natural
defenses and immune regulating functions. It should be noted that in
people with severely impaired digestion, the absorption of large
polysaccharides (like other nutrients in the diet) may be impaired.
Coriolus versicolor deserves a comprehensive review in Townsend Letter,
and other journals. It is an example of one product that has proved
itself extensively, yet remains outside the general practice in America
due to the current restrictions on commercial speech, as well as the
outdated drug laws and patent regulations.
In Japan, where PSK
is dispensed as an authorized drug, it is sold for approximately $1,000
per month at a dosage of 3 grams per day. As a US food product, this
same monthly supply is sold for $149 retail. This explains much of why
natural products that can’t be owned on a proprietary basis don’t make
their way into the American medical model: Effective
and safe products that can’t generate the profits that our
pharmaceutical industry has come to expect will not become the
medicines of the future until the laws of today are changed.
We can try to fix our system, one piece at a time, or we can begin
leveling the playing field by letting science, and not special interest
economics, guide our future directions. Then we can truly begin to own our own health.
Coriolus versicolor standardized extract from JHS Natural Products has recently been trademarked in the United States as VPS
and is manufactured to the same specifications as PSK. VPS is available
at the discounted price of $90.00 per bottle Buy
Now Here
References
1. Torisu, M., et al. (1990). Significant prolongation of disease-free
period gained by oral polysaccharide K (PSK) administration after
curative surgical operation of colorectal cancer. Cancer Immunology Immunotherapy 31(5), 261-268.
2. Hayakawa, K., et al. (1993). Effect of Krestin (PSK) as Adjuvant
Treatment on the Prognosis after Radical Radiotherapy in Patients with
Non-Small Cell Lung Cancer. Anticancer Research 13, 1815-1820.
3. Ilino, Y., et al. (1995). Immunochemotherapies vs. Chemotherapy as
Adjuvant Treatment after Curative Resection of Operable Breast Cancer. Anticancer Research 15, 2907-2912
4. Nakazato, H., et al. (1994). Efficacy of Immunochemotherapy as
Adjuvant Treatment after Curative Resection of Gastric Cancer. Lancet 343, 1122-1126.
5. Sakagami, H. and Takeda M. (1993). Diverse Biological Activity of
PSK (KRESTIN), A Protein-Bound Polysaccharide from Coriolus versicolor
(Fr.) Quel. Proceedings of the First International Conference on
Mushroom Biology and Mushroom products, August 23-26, 1993, The Chinese
University of Hong Kong, Hong Kong. Mushroom Biology and Mushroom Products. Chang, S.-T. et al. (eds.). Shatin, Hong Kong: Chinese University Press: 237-245.
5. Ikusawa, M., et al. (1988). Fate and Distribution of an Antitumor Protein-Bound Polysaccharide PSK (KRESTIN). International Journal of Immunopharmacology 10(4), 415-423.
Return to articles list
This article is up with express permission from Wildfire Natural Products.
©Copyright 1996-2002 Wildfire Natural Products. All Rights Reserved.
|
Think Right
For Success in Health and Life!
The #1 Most Visited Personal Development Site
Just Can't Get Motivated? Need help in Achieving Your
Goals?
- Need to Stop Smoking ? Lose Weight? Conquer
Depression?
- It All Starts From Within! To be successful you must Think Like a
Winner!
Join
people from 54 countries now using the
New Paradigm in personal growth
Kate Clifton
P.O. Box 151191 San Diego, Ca
92175
760-458-2151
www.womenshealth-naturalsolutions.com
herbladyisin@yahoo.com
www.oralchelationanswers.com
www.herbladyisin.com
www.heavymetalpoisoninghelp.com
www.leadpoisoninghelp.com
The #1 Most Visited Personal
Development Site
Just Can't Get Motivated?
Need Help In Achieving Your Goals
Need to Stop Smoking?
Need Help in Goal Setting?
It All Starts from Within!
To Be a Winner You Must Think Like a Winner1
Join people from 54 countries
now using the New Paradign in Personal Growth!
Kate
Clifton
P.O. Box 151191
San
Diego, Ca 92175
760-458-2151
Info@womenshealth-naturalsolutions.com
counseling@womenshealth-naturalsolutions.com
www.oralchelationanswers.com
www.herbladyisin.com
www.heavymetalpoisoninghelp.com
www.leadpoisoninghelp.com
Copyright ©
www.herbladyisin.com
Copyright ©
'The-herbladyisin'
Copyright © 1999 by Women's Health-
Natural Solutions.Com
All rights reserved.
Revised: 03-08-05:43:25
-0400 .
Disclaimer: Important- Read
Carefully
*NOTE: The opinions and views expressed on this site are
from Kate Clifton and
other alternative medicine authors and are protected by
Copyright and Freedom of Speech
laws in the United States.
These statements have NOT
been evaluated by the Food and Drug Administration.
These products are
not intended to diagnose, treat, cure, or prevent any
disease.
It is advised to
always seek
the advice from your family holistic physician before starting
any new herbal or nutritional program.
Click the button
below to find a holistic doctor in your area
Click
Below
Holistic
Doctors and Clinics.htm
|